| Screening set (n = 63) | Validation set (n = 86) |
---|---|---|
Characteristics | n (%) | n (%) |
Histology | Â | Â |
Serous | 28 (44.4) | 86 (100.0) |
Non-serous | 35 (55.6) 1 | - |
FIGO | Â | Â |
I | 19 (30.2) | 6 (7.0) |
II | 6 (9.5) | 4 (4.7) |
III | 32 (50.8) | 61 (70.9) |
IV | 6 (9.5) | 15 (17.4) |
Grade | Â | Â |
Grade 1 | 10 (15.9) | 6 (7.0) |
Grade 2 | 20 (31.7) | 19 (22.1) |
Grade 3 | 33 (52.4) | 61 (70.9) |
Residual tumor | Â | Â |
no | 35 (55.6) | 37 (43.0) |
> 0 cm | 28 (44.4) | 49 (57.0) |
ERα |  |  |
positive | 13 (20.6) | 27 (31.4) |
negative | 49 (77.8) | 55 (63.9) |
missing | 1 (1.5) | 4 (4.7) |
ERbeta | Â | Â |
positive | 45 (71.4) | 14 (16.3) |
negative | 15 (23.8) | 68 (79.0) |
missing | 3 (4.7) | 4 (4.7) |
PELP1 | Â | Â |
positive | 48 (76.2) | 21 (24.4) |
negative | 12 (19.0) | 61 (70.9) |
missing | 3 (4.7) | 4 (4.7) |